$110.33
-0.17-0.15%
At Close: -
$110.33
00.00%
After Hours: 5:08 PM EDT
15 minutes delayed
Comments
Loading...
Zimmer Biomet Holdings
ZBHNYSE
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Zimmer Biomet Holdings (NYSE:ZBH) Stock, Analyst Ratings, Price Targets, Forecasts
Zimmer Biomet Holdings Inc has a consensus price target of $135.27 based on the ratings of 28 analysts. The high is $172 issued by Baird on June 28, 2023. The low is $112 issued by UBS on March 29, 2023. The 3 most-recent analyst ratings were released by Truist Securities, Morgan Stanley, and Citigroup on July 16, 2024, July 15, 2024, and July 10, 2024, respectively. With an average price target of $119 between Truist Securities, Morgan Stanley, and Citigroup, there's an implied 7.86% upside for Zimmer Biomet Holdings Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Truist Securities
Morgan Stanley
Citigroup
Evercore ISI Group
Piper Sandler
1calculated from analyst ratings
Analyst Ratings for Zimmer Biomet Holdings
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 07/16/2024 | Buy Now | 6.05% | Truist Securities | Richard Newitter | $130 → $117 | Maintains | Hold | Get Alert |
| 07/15/2024 | Buy Now | 8.76% | Morgan Stanley | Cecilia Furlong | $130 → $120 | Maintains | Equal-Weight | Get Alert |
| 07/10/2024 | Buy Now | 8.76% | Citigroup | Joanne Wuensch | $134 → $120 | Maintains | Neutral | Get Alert |
| 07/02/2024 | Buy Now | 4.23% | Evercore ISI Group | Vijay Kumar | $130 → $115 | Maintains | In-Line | Get Alert |
| 07/01/2024 | Buy Now | 4.23% | Piper Sandler | Matthew O'Brien | $140 → $115 | Downgrade | Overweight → Neutral | Get Alert |
| 05/31/2024 | Buy Now | 13.3% | Barclays | Matt Miksic | $130 → $125 | Maintains | Underweight | Get Alert |
| 05/30/2024 | Buy Now | 16.92% | Goldman Sachs | David Roman | → $129 | Initiates | → Neutral | Get Alert |
| 05/30/2024 | Buy Now | — | Needham | Mike Matson | — | Reiterates | → Hold | Get Alert |
| 05/21/2024 | Buy Now | 35.96% | Argus Research | David Toung | → $150 | Upgrade | Hold → Buy | Get Alert |
| 05/17/2024 | Buy Now | — | Needham | Mike Matson | — | Reiterates | → Hold | Get Alert |
| 05/03/2024 | Buy Now | 17.83% | Truist Securities | Richard Newitter | $137 → $130 | Maintains | Hold | Get Alert |
| 05/03/2024 | Buy Now | 40.49% | Oppenheimer | Steven Lichtman | $150 → $155 | Maintains | Outperform | Get Alert |
| 05/02/2024 | Buy Now | — | Needham | Mike Matson | — | Reiterates | → Hold | Get Alert |
| 04/04/2024 | Buy Now | 17.83% | Evercore ISI Group | Vijay Kumar | $125 → $130 | Maintains | In-Line | Get Alert |
| 04/03/2024 | Buy Now | 26.89% | Citigroup | Joanne Wuensch | $134 → $140 | Maintains | Neutral | Get Alert |
| 02/23/2024 | Buy Now | 17.83% | Canaccord Genuity | Caitlin Cronin | → $130 | Reiterates | Hold → Hold | Get Alert |
| 02/12/2024 | Buy Now | 17.83% | Barclays | Matt Miksic | $120 → $130 | Maintains | Underweight | Get Alert |
| 02/09/2024 | Buy Now | 22.36% | Truist Securities | Richard Newitter | $133 → $135 | Maintains | Hold | Get Alert |
| 02/09/2024 | Buy Now | 13.3% | JP Morgan | Robbie Marcus | $115 → $125 | Maintains | Neutral | Get Alert |
| 02/09/2024 | Buy Now | 26.89% | RBC Capital | Shagun Singh | → $140 | Reiterates | Outperform → Outperform | Get Alert |
| 01/12/2024 | Buy Now | 26.89% | RBC Capital | Shagun Singh | $134 → $140 | Maintains | Outperform | Get Alert |
| 01/04/2024 | Buy Now | 13.3% | Evercore ISI Group | Vijay Kumar | $135 → $125 | Downgrade | Outperform → In-Line | Get Alert |
| 01/03/2024 | Buy Now | 24.17% | Raymond James | Jayson Bedford | $133 → $137 | Maintains | Outperform | Get Alert |
| 12/22/2023 | Buy Now | 20.55% | Truist Securities | Richard Newitter | $115 → $133 | Maintains | Hold | Get Alert |
| 12/04/2023 | Buy Now | 13.3% | Morgan Stanley | Cecilia Furlong | $120 → $125 | Maintains | Equal-Weight | Get Alert |
| 11/13/2023 | Buy Now | 26.89% | JMP Securities | David Turkaly | $160 → $140 | Maintains | Market Outperform | Get Alert |
| 11/09/2023 | Buy Now | 20.55% | Raymond James | Jayson Bedford | $160 → $133 | Maintains | Outperform | Get Alert |
| 11/08/2023 | Buy Now | 8.76% | Morgan Stanley | Cecilia Furlong | $140 → $120 | Maintains | Equal-Weight | Get Alert |
| 11/08/2023 | Buy Now | 4.23% | JP Morgan | Robbie Marcus | $146 → $115 | Maintains | Neutral | Get Alert |
| 10/20/2023 | Buy Now | 8.76% | Roth MKM | Jason Wittes | → $120 | Initiates | → Neutral | Get Alert |
| 10/02/2023 | Buy Now | 13.3% | Citigroup | Joanne Wuensch | $146 → $125 | Maintains | Neutral | Get Alert |
| 08/28/2023 | Buy Now | 25.99% | BTIG | Ryan Zimmerman | → $139 | Upgrade | Neutral → Buy | Get Alert |
| 08/02/2023 | Buy Now | 34.14% | Truist Securities | Richard Newitter | $153 → $148 | Maintains | Hold | Get Alert |
| 08/02/2023 | Buy Now | 26.89% | Morgan Stanley | Cecilia Furlong | $140 → $140 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 08/02/2023 | Buy Now | 45.02% | JMP Securities | David Turkaly | → $160 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 08/02/2023 | Buy Now | 42.3% | Oppenheimer | Steven Lichtman | → $157 | Reiterates | Outperform → Outperform | Get Alert |
| 08/02/2023 | Buy Now | 8.76% | Barclays | Matt Miksic | $116 → $120 | Maintains | Underweight | Get Alert |
| 07/19/2023 | Buy Now | 38.67% | Truist Securities | Richard Newitter | $147 → $153 | Maintains | Hold | Get Alert |
| 06/28/2023 | Buy Now | 55.9% | Baird | Jeff Johnson | → $172 | Reiterates | Outperform → Outperform | Get Alert |
| 06/02/2023 | Buy Now | 49.55% | Stifel | Rick Wise | $165 → $165 | Maintains | Buy | Get Alert |
| 05/31/2023 | Buy Now | 26.89% | Morgan Stanley | Cecilia Furlong | $150 → $140 | Maintains | Equal-Weight | Get Alert |
| 05/28/2023 | Buy Now | 49.55% | Stifel | Rick Wise | $165 → $165 | Maintains | Buy | Get Alert |
| 05/18/2023 | Buy Now | 49.55% | Stifel | Rick Wise | $160 → $165 | Maintains | Buy | Get Alert |
| 05/18/2023 | Buy Now | 33.24% | Truist Securities | Richard Newitter | $153 → $147 | Maintains | Hold | Get Alert |
| 05/04/2023 | Buy Now | 5.14% | Barclays | Matt Miksic | $105 → $116 | Maintains | Underweight | Get Alert |
| 05/03/2023 | Buy Now | 45.02% | Stifel | Rick Wise | → $160 | Maintains | Buy | Get Alert |
| 05/03/2023 | Buy Now | 32.33% | Citigroup | Joanne Wuensch | $130 → $146 | Maintains | Neutral | Get Alert |
| 05/03/2023 | Buy Now | 38.67% | Truist Securities | Richard Newitter | $137 → $153 | Maintains | Hold | Get Alert |
| 05/03/2023 | Buy Now | 45.02% | B of A Securities | Travis Steed | $120 → $160 | Upgrade | Underperform → Neutral | Get Alert |
| 05/03/2023 | Buy Now | 35.96% | Morgan Stanley | Cecilia Furlong | $140 → $150 | Maintains | Equal-Weight | Get Alert |
| 05/03/2023 | Buy Now | 41.39% | RBC Capital | Shagun Singh | $141 → $156 | Maintains | Outperform | Get Alert |
| 05/03/2023 | Buy Now | 45.02% | Raymond James | Jayson Bedford | $144 → $160 | Maintains | Outperform | Get Alert |
| 05/03/2023 | Buy Now | 55.9% | Baird | Jeff Johnson | $145 → $172 | Maintains | Outperform | Get Alert |
| 05/03/2023 | Buy Now | 45.02% | JMP Securities | David Turkaly | $145 → $160 | Maintains | Outperform | Get Alert |
| 05/03/2023 | Buy Now | 37.77% | Bernstein | Lee Hambright | $136 → $152 | Maintains | Market Perform | Get Alert |
| 04/11/2023 | Buy Now | 34.14% | Evercore ISI Group | Vijay Kumar | $135 → $148 | Upgrade | In-Line → Outperform | Get Alert |
| 03/31/2023 | Buy Now | 17.83% | Jefferies | Matthew Taylor | $115 → $130 | Upgrade | Underperform → Hold | Get Alert |
| 03/29/2023 | Buy Now | 1.51% | UBS | Danielle Antalffy | → $112 | Initiates | → Sell | Get Alert |
| 03/10/2023 | Buy Now | — | Piper Sandler | Matt O'Brien | — | Upgrade | Neutral → Overweight | Get Alert |
| 02/07/2023 | Buy Now | 31.42% | JMP Securities | David Turkaly | → $145 | Reiterates | → Market Outperform | Get Alert |
| 02/06/2023 | Buy Now | 24.17% | Truist Securities | Richard Newitter | $135 → $137 | Maintains | Hold | Get Alert |
| 02/06/2023 | Buy Now | 26.89% | Morgan Stanley | Cecilia Furlong | $135 → $140 | Maintains | Equal-Weight | Get Alert |
| 02/06/2023 | Buy Now | 28.7% | Oppenheimer | Steven Lichtman | $120 → $142 | Maintains | Outperform | Get Alert |
| 02/05/2023 | Buy Now | 35.96% | Stifel | Rick Wise | → $150 | Maintains | Buy | Get Alert |
| 01/27/2023 | Buy Now | 28.7% | Stifel | Rick Wise | → $142 | Maintains | Buy | Get Alert |
| 01/11/2023 | Buy Now | -84.05% | JP Morgan | Robbie Marcus | $19.8 → $17.6 | Maintains | Neutral | Get Alert |
| 01/09/2023 | Buy Now | 27.8% | RBC Capital | Shagun Singh | $125 → $141 | Upgrade | Sector Perform → Outperform | Get Alert |
| 01/08/2023 | Buy Now | 28.7% | Stifel | Rick Wise | → $142 | Maintains | Buy | Get Alert |
| 01/06/2023 | Buy Now | 22.36% | Morgan Stanley | Cecilia Furlong | $120 → $135 | Maintains | Equal-Weight | Get Alert |
| 01/05/2023 | Buy Now | 17.83% | Piper Sandler | Matthew O'Brien | $120 → $130 | Maintains | Neutral | Get Alert |
| 01/05/2023 | Buy Now | 30.52% | Raymond James | Jayson Bedford | → $144 | Upgrade | Market Perform → Outperform | Get Alert |
| 01/03/2023 | Buy Now | 17.83% | Evercore ISI Group | Vijay Kumar | → $130 | Downgrade | Outperform → In-Line | Get Alert |
| 12/20/2022 | Buy Now | 22.36% | Truist Securities | Richard Newitter | $120 → $135 | Maintains | Hold | Get Alert |
| 12/12/2022 | Buy Now | 17.83% | Citigroup | Joanne Wuensch | $116 → $130 | Maintains | Neutral | Get Alert |
| 11/23/2022 | Buy Now | 12.39% | Wells Fargo | Larry Biegelsen | $116 → $124 | Upgrade | Underweight → Equal-Weight | Get Alert |
| 11/03/2022 | Buy Now | 13.3% | RBC Capital | Shagun Singh | $128 → $125 | Maintains | Sector Perform | Get Alert |
| 11/03/2022 | Buy Now | 5.14% | Citigroup | Joanne Wuensch | $119 → $116 | Maintains | Neutral | Get Alert |
| 10/18/2022 | Buy Now | -5.74% | Barclays | Matt Miksic | → $104 | Initiates | → Underweight | Get Alert |
| 10/12/2022 | Buy Now | -13.89% | Jefferies | Matthew Taylor | → $95 | Initiates | → Underperform | Get Alert |
| 08/03/2022 | Buy Now | 13.3% | Truist Securities | Richard Newitter | $115 → $125 | Maintains | Hold | Get Alert |
| 08/03/2022 | Buy Now | 7.86% | Citigroup | Joanne Wuensch | $114 → $119 | Maintains | Neutral | Get Alert |
| 08/03/2022 | Buy Now | 8.76% | Morgan Stanley | Cecilia Furlong | $115 → $120 | Maintains | Equal-Weight | Get Alert |
| 08/02/2022 | Buy Now | 8.76% | Piper Sandler | Matthew O'Brien | $130 → $120 | Maintains | Neutral | Get Alert |
| 08/02/2022 | Buy Now | 25.08% | Baird | Jeff Johnson | $172 → $138 | Maintains | Outperform | Get Alert |
| 07/18/2022 | Buy Now | 8.76% | Stifel | Rick Wise | $140 → $120 | Maintains | Buy | Get Alert |
| 07/15/2022 | Buy Now | 4.23% | Morgan Stanley | Cecilia Furlong | $132 → $115 | Maintains | Equal-Weight | Get Alert |
| 05/27/2022 | Buy Now | — | Needham | Mike Matson | — | Downgrade | Buy → Hold | Get Alert |
| 05/17/2022 | Buy Now | 13.3% | Citigroup | Joanne Wuensch | $135 → $125 | Maintains | Neutral | Get Alert |
| 05/04/2022 | Buy Now | 18.73% | Truist Securities | Richard Newitter | $142 → $131 | Maintains | Hold | Get Alert |
| 05/04/2022 | Buy Now | 16.02% | RBC Capital | Shagun Singh | $125 → $128 | Maintains | Sector Perform | Get Alert |
| 05/04/2022 | Buy Now | 26.89% | SVB Leerink | Danielle Antalffy | $135 → $140 | Maintains | Outperform | Get Alert |
| 05/03/2022 | Buy Now | 26.89% | Stifel | Rick Wise | $130 → $140 | Maintains | Buy | Get Alert |
| 05/03/2022 | Buy Now | 17.83% | Piper Sandler | Matthew O'Brien | $110 → $130 | Maintains | Neutral | Get Alert |
| 05/03/2022 | Buy Now | 25.08% | Baird | Jeff Johnson | → $138 | Maintains | Outperform | Get Alert |
| 04/01/2022 | Buy Now | 16.92% | Citigroup | Joanne Wuensch | $125 → $129 | Downgrade | Buy → Neutral | Get Alert |
| 03/21/2022 | Buy Now | 40.49% | Goldman Sachs | — | $179 → $155 | Maintains | Buy | Get Alert |
| 03/02/2022 | Buy Now | 17.83% | Loop Capital | Jason Wittes | → $130 | Downgrade | Buy → Hold | Get Alert |
| 02/09/2022 | Buy Now | 26.89% | Loop Capital | Jason Wittes | $165 → $140 | Maintains | Buy | Get Alert |
| 02/08/2022 | Buy Now | 16.92% | Citigroup | Joanne Wuensch | $150 → $129 | Maintains | Buy | Get Alert |
| 02/08/2022 | Buy Now | 16.02% | Truist Securities | Richard Newitter | $145 → $128 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Zimmer Biomet Holdings (ZBH) stock?
The latest price target for Zimmer Biomet Holdings (NYSE:ZBH) was reported by Truist Securities on July 16, 2024. The analyst firm set a price target for $117.00 expecting ZBH to rise to within 12 months (a possible 6.05% upside). 37 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Zimmer Biomet Holdings (ZBH)?
The latest analyst rating for Zimmer Biomet Holdings (NYSE:ZBH) was provided by Truist Securities, and Zimmer Biomet Holdings maintained their hold rating.
When was the last upgrade for Zimmer Biomet Holdings (ZBH)?
The last upgrade for Zimmer Biomet Holdings Inc happened on May 21, 2024 when Argus Research raised their price target to $150. Argus Research previously had a hold for Zimmer Biomet Holdings Inc.
When was the last downgrade for Zimmer Biomet Holdings (ZBH)?
The last downgrade for Zimmer Biomet Holdings Inc happened on July 1, 2024 when Piper Sandler changed their price target from $140 to $115 for Zimmer Biomet Holdings Inc.
When is the next analyst rating going to be posted or updated for Zimmer Biomet Holdings (ZBH)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Zimmer Biomet Holdings, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Zimmer Biomet Holdings was filed on July 16, 2024 so you should expect the next rating to be made available sometime around July 16, 2025.
Is the Analyst Rating Zimmer Biomet Holdings (ZBH) correct?
While ratings are subjective and will change, the latest Zimmer Biomet Holdings (ZBH) rating was a maintained with a price target of $130.00 to $117.00. The current price Zimmer Biomet Holdings (ZBH) is trading at is $110.33, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.